Back
Sarepta Therapeutics, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
49
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$23.35
Seasonality Move:
4.67%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.02 | Buy |
| 20-day SMA: | 21.79 | Buy |
| 50-day SMA: | 20.65 | Buy |
| 200-day SMA: | 27.99 | Sell |
| 8-day EMA: | 22.3 | Buy |
| 20-day EMA: | 21.78 | Buy |
| 50-day EMA: | 21.19 | Buy |
| 200-day EMA: | 36.14 | Sell |
Sarepta Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 60.52 | Buy |
| Chaikin Money Flow: | -1808020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.19 - 22.55) | Buy |
| Bollinger Bands (100): | (18.09 - 22.57) | Buy |
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics, Inc. Stock
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 23.15 while SRPT 8-day simple moving average is 22.02, which is a Buy signal.
-
The stock price of SRPT is 23.15 while Sarepta Therapeutics, Inc. 20-day SMA is 21.79, which makes it a Buy.
-
Sarepta Therapeutics, Inc. 50-day simple moving average is 20.65 while SRPT share price is 23.15, making it a Buy technically.
-
SRPT stock price is 23.15 and Sarepta Therapeutics, Inc. 200-day simple moving average is 27.99, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
49
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy or a Sell?
-
Sarepta Therapeutics, Inc. stock is rated a SellThe current Sarepta Therapeutics, Inc. [SRPT] share price is $23.15. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics, Inc. Stock Info
Market Cap:
2.4B
Price in USD:
23.15
Share Volume:
3.1M
Sarepta Therapeutics, Inc. 52-Week Range
52-Week High:
128.75
52-Week Low:
10.42
Sell
49
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Sarepta Therapeutics, Inc. Share Price Forecast
-
What is the Sarepta Therapeutics, Inc. stock price today?The Sarepta Therapeutics, Inc. stock price is 23.15 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics, Inc. is overvalued.
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 23.15 while SRPT 8-day exponential moving average is 22.30, which is a Buy signal.
-
The stock price of SRPT is 23.15 while Sarepta Therapeutics, Inc. 20-day EMA is 21.78, which makes it a Buy.
-
Sarepta Therapeutics, Inc. 50-day exponential moving average is 21.19 while SRPT share price is 23.15, making it a Buy technically.
-
SRPT stock price is 23.15 and Sarepta Therapeutics, Inc. 200-day simple moving average is 36.14, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics, Inc.
Is Sarepta Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.76 per share, and an increase next year of $0.24 per share.
Technical Analysis of Sarepta Therapeutics, Inc.
Should I short Sarepta Therapeutics, Inc. stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is 0.49, suggesting Sarepta Therapeutics, Inc. is a Buy
-
Sarepta Therapeutics, Inc. Relative Strength Index (RSI) is 60.52, which suggest Sarepta Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Sarepta Therapeutics, Inc. is (21.19 - 22.55), which suggest Sarepta Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Sarepta Therapeutics, Inc. is (18.09 - 22.57), which suggest Sarepta Therapeutics, Inc. is a Buy
* Sarepta Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.